sprite-preloader
Anzeige
Mehr »
Samstag, 15.12.2018 Börsentäglich über 12.000 News von 601 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Passende Knock-Outs zu Ihrer Suchanfrage (Anzeige)
Erweiterte
Suche
lynx
Ad hoc-Mitteilungen

Aktuelle News von Pharmaceutical Business Review

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
FrBausch Health signs stalking horse agreement to buy Synergy Pharmaceuticals
FrNovartis gets EC approval for self-administration of Xolair across all indications
FrAMAG Pharmaceuticals to buy biopharmaceutical firm Perosphere
DoX-Chem, Almirall forge dermatology-focused drug discovery alliance
DoWeizmann researchers discover new neural mechanism underlying anxiety
DoJanssen's Tremfya meets primary endpoint in phase 3 psoriasis trial
MiSchrödinger, TB Alliance collaborate to advance tuberculosis drug discovery
MiVersant Ventures launches new biotech firm Black Diamond Therapeutics
MiCircassia to acquire full US rights of AstraZeneca's COPD treatment Tudorza
DiAlnylam, Silence Therapeutics settle patent dispute
Die-therapeutics, Novo Nordisk enter into research collaboration agreement
DiPCI expands cold chain storage capabilities at UK site
DiBMS, Vedanta Biosciences to evaluate Opdivo-VE800 combo in metastatic cancers
MoFrench pharma firm Cristers selects Adents Prodigi serialisation solution
MoEisai, UCL to launch phase I trials of E2814 for Alzheimer's disease
MoAstraZeneca's Imfinzi fails to improve OS in head and neck cancer trial
07.12.AstraZeneca divests asthma and rhinitis drug rights to Covis Pharma
06.12.Mereo BioPharma, OncoMed Pharmaceuticals proposes merger deal
06.12.Tris Pharma recalls infants' liquid Ibuprofen in US
06.12.Biopharmaceutical firm UCB to invest £1bn in UK for research and development
05.12.Novartis initiates phase III trials of ligelizumab in urticaria
05.12.Ixico secures expanded contract from major biopharmaceutical firm
05.12.J&J's Darzalex reduces disease progression in multiple myeloma study
04.12.Momenta revises regulatory strategy for proposed Humira biosimilar
04.12.TRIGR Therapeutics, ABL Bio sign license agreement for bispecific antibody candidate